comparemela.com

Page 3 - Adeno Associated Viral News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DGAP-News: AAVantgarde Bio Appoints Dr Natalia Misciattelli as Chief Executive Officer Seite 1

08.09.2022 - DGAP-News: Sofinnova Partners / Key word(s): Personnel AAVantgarde Bio Appoints Dr. Natalia Misciattelli as Chief Executive Officer 08.09.2022 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. AAVantgarde Bio . Seite 1

AAVantgarde Bio Appoints Dr Natalia Misciattelli as Chief Executive Officer

Sofinnova Partners: AAVantgarde Bio Appoints Dr Natalia Misciattelli as Chief Executive Officer

MILAN, ITALY / ACCESSWIRE / September 8, 2022 / AAVantgarde Bio, a clinical stage Milan-based international biotechnology start-up that has developed proprietary Adeno-Associated Viral (AAV) vector platforms

DGAP-News: Sofinnova Partners: AAVantgarde Announces the Appointment of Naveed Shams, M D , Ph D as Chief Development and Medical Officer

DGAP-News: Sofinnova Partners / Key word(s): Personnel Sofinnova Partners: AAVantgarde Announces the Appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer 30.06.2022 / 08:00 The issuer is solely responsible for the content of this announcement. AAVantgarde Announces t.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.